HHMI
ACN icon

Howard Hughes Medical Institute’s Accenture ACN Stock Holding History

Howard Hughes Medical Institute’s Portfolio ACN Stock Details ACN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.71M Buy
8,607
+8,473
+6,323% +$1.97M 0.41% 30
2025
Q4 		$36K Hold
134
– – 0.02% 66
2025
Q3 		$33K Sell
134
-1
-0.7% -$261 0.02% 69
2025
Q2 		$40.4K Buy
+135
New +$41.1K 0.02% 50

Other funds holding ACN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Howard Hughes Medical Institute's ACN Position: Q1 2026 in Review

Howard Hughes Medical Institute increased its Accenture (ACN) stake by 6,323% in Q1 2026, buying an estimated $1.97M and bringing the position to 8,607 shares worth $1.71M. The position accounts for 0.41% of the portfolio, ranked #30.

Howard Hughes Medical Institute first reported a position in ACN in Q2 2025 and has held it in 4 quarters since. 2,151 funds tracked by Wall St. Rank hold ACN as of Q1 2026.

  • Howard Hughes Medical Institute held 8,607 shares of Accenture worth $1.71M as of Q1 2026.
  • Howard Hughes Medical Institute bought 8,473 Accenture shares in Q1 2026, an estimated $1.97M.
  • Accenture made up 0.41% of Howard Hughes Medical Institute's portfolio in Q1 2026, its #30 holding.
  • Howard Hughes Medical Institute first reported a position in Accenture in Q2 2025 and has held it in 4 quarters since.
  • 2,151 funds tracked by Wall St. Rank held Accenture as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.